26hrs after injection, had chills for 5hrs followed by fever on and off through the night; 26hrs after injection, had chills for 5hrs followed by fever on and off through the night; A week later site is still discolored/bruised looking; A week later site is still discolored/bruised looking; About 24hrs after 2nd injection, injection site started to itch and was hot to touch. Itching continued for several days.; About 24hrs after 2nd injection, injection site started to itch and was hot to touch.; Site was red and swollen and increased in size for two days.; Site was red and swollen and increased in size for two days.; Site was painful to touch for a week.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 09Apr2021 at 12:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included sport induced asthma, penicillin allergy, allergy to cephalosporins and sulfonamide allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had received Kroger brand allergy medicine within two weeks of vaccination on unknown date and was unknown if ongoing. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and hydrocodone bitartrate; paracetamol (VICODIN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 19Mar2021 at 11:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021, about 24hrs after second injection, injection site started to itch and was hot to touch. Itching continued for several days. Site was red and swollen and increased in size for two days. Site was painful to touch for a week. On 10Apr2021 at 14:00, 26 hours after injection, the patient had chills for 5 hours followed by fever on and off through the night. A week later site was still discolored or bruised looking. Therapeutic measures were taken as a result of pain and fever and included treatment with paracetamol (TYLENOL). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event about 24hrs after second injection, injection site started to itch and was hot to touch; itching continued for several days; site was red was resolved on an unknown date in Apr2021, while that of swollen and increased in size for two days was resolved on 12Apr2021. The clinical outcome of the event site was painful to touch for a week was resolved on 17Apr2021. The clinical outcome of the event 26 hours after injection, had chills for 5 hours was resolved on 10Apr2021 at 19:00, followed by fever on and off through the night was resolved on an unknow date in Apr2021. The clinical outcome of the event a week later site is still discolored or bruised looking was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.